EVIO, Inc. Successfully Completes Debt Restructuring of Leaf Detective Note

Rhea-AI Summary

EVIO, Inc. (OTC PINK:EVIO) announced the successful completion of a debt restructuring plan, settling approximately $596,000 of debt for about $205,000. This restructuring is part of a broader cost reduction strategy aimed at achieving profitability, which will be detailed in future updates. The debt was linked to the acquisition of Leaf Detective, LLC, and a related lawsuit will be dismissed post-settlement. The settlement proceeds came from asset sales to PREE Laboratories, without issuing new stock.

Positive

• Successfully settled $596,000 debt for $205,000, reducing financial liabilities.
• Initiating a multi-phase cost reduction strategy to enhance profitability.

Negative

• Debt reduction linked to previous acquisition raises concerns about past financial mismanagement.
• Ongoing risks related to a lawsuit and uncertainty of future financial results.

HENDERSON, NV / ACCESSWIRE / November 3, 2022 / EVIO, Inc. (OTC PINK:EVIO) is pleased to announce that it has successfully completed a restructuring (the "Debt Restructuring") and settled approximately $596,000 (the "Deferred Amount") of the Company's outstanding debt for approximately $205,000.

Over the next year, EVIO plans to execute on a cost reduction strategy in order to become profitable. The strategy consists of several phases and the Company plans to issue updates on the process over the coming months. This Debt Restructuring transaction is the first step of the multi-phase cost reduction strategy and falls in-line with the management team's plan to reduce historical debt, minimize dilution, and strengthen the balance sheet.

This debt was associated with the acquisition of Leaf Detective, LLC, on April 25, 2018. EVIO Inc. guaranteed this debt on behalf of its wholly owned subsidiary EVIO Labs Humboldt, LLC. The lawsuit associated with this transaction dated April 24, 2020, in which Creditors filed a complaint for breach of contract against EVIO, Inc., in the Superior Court of California for the County of Humboldt, under Case No. CV2000495 (the "California Lawsuit"), in the amount of $500,000 plus interest will be satisfied and fully dismissed upon payment per the terms of this agreement.

"We're actively pursuing initiatives to reduce both expenses and debt," said EVIO CEO, William Waldrop. "This settlement is a crucial step in the process of cleaning up EVIO's Balance Sheet and optimizing Cash Flows in order to better position the Company to raise capital, continue executing our fundamental strategy, and provide the necessary scale to fuel the growth we believe we're capable of achieving."

The proceeds for the settlement came from the sale of the EVIO Labs Portland's assets to PREE Laboratories. No new shares of common stock were issued as part of this settlement.

About EVIO

EVIO, Inc. ("EVIO") is a diversified holding company, focused on Construction Services and Pharmaceutical Testing. In Florida, the Company offers general contractor services serving the residential and commercial construction industry. In Canada, via its ownership in Keystone, the Company provides pharmaceutical, environmental, stability and analytical testing.

For more information, visit www.evioinc.com

Safe Harbor Statement

Any statements in this press release that are not statements of historical fact may be considered forward-looking statements pertaining to anticipated or projected plans, performance, and developments, as well as other statements relating to future operations and results. Words such as "may," "will," "expect," "believe," "anticipate," "estimate," "intends," "goal," "objective," "seek," "attempt," or variations of these or similar words, identify forward-looking statements. These forward-looking statements by their nature are estimates of future results only, and involve substantial risks and uncertainties, including but not limited to risks associated with the uncertainty of future financial results, additional financing requirements, development of new products, the Company's ability to complete product testing and launch product commercially, the acceptance of product in the marketplace, the uncertainty of the laws and regulations relating to cannabis, the impact of competitive products or pricing, technological changes, the effect of economic conditions and other uncertainties detailed from time to time in Company reports available at www.evioinc.com.

For more information:

EVIO Inc.
William Waldrop, CEO
Email: info@evioinc.com
Phone (702) 748-9944

SOURCE: EVIO, Inc.

View source version on accesswire.com:
https://www.accesswire.com/723720/EVIO-Inc-Successfully-Completes-Debt-Restructuring-of-Leaf-Detective-Note

FAQ

What is the recent debt restructuring announcement by EVIO Inc. about?

EVIO Inc. announced a successful completion of a debt restructuring plan, settling approximately $596,000 of outstanding debt for about $205,000.

How much debt did EVIO settle and what was the cost?

EVIO settled about $596,000 in debt for approximately $205,000.

What is the purpose of EVIO's cost reduction strategy?

The cost reduction strategy aims to achieve profitability and strengthen the company's financial position.

What will happen to the lawsuit associated with EVIO's debt?

The lawsuit related to the debt will be satisfied and fully dismissed upon payment per the terms of the settlement.

How did EVIO fund the debt settlement?

The settlement was funded through the sale of assets from EVIO Labs Portland to PREE Laboratories.